MGMA Report Reveals Significant Increase in Regulatory Burden on Medical Practices

The Medical Group Management Association (MGMA) has released its 2022 Annual Regulatory Burden Report. With responses from over 500 medical group practices, survey findings included within the report reveal the true and significant impact of federal regulations on the U.S. healthcare system. MGMA’s Government Affairs team utilizes this critical data to inform Congress and the Administration about the obstacles faced by medical practices to delivering high-quality patient care.

An overwhelming majority (89%) of respondents reported that the overall regulatory burden on their medical practice has increased over the past 12 months. Even more respondents (97%) agreed a reduction in regulatory burden would allow their practice to reallocate resources toward patient care. Prior authorization requirements once again ranked as the top burden for medical practices, with requirements stemming from the No Surprises Act and Medicare’s Quality Payment Program coming in second and third. Read more.

Total
0
Shares
Related Posts
Read More

New Financing Products Take Pain Out of Healthcare Payments

One new entrant in this up-and-coming category is TempoPay, a zero-interest credit card from Redesign Health that lets consumers pay off pricey procedures in installments. While not a new idea, the launch of a new healthcare line of credit points to the potential of the concept as well as demand in the marketplace.